The pathogenesis of MASLD is complex, involving lipotoxicity, OS, insulin resistance (IR), and changes in the gut microbiota (GM) (Figure 1), which schematically illustrates the multifactorial etiology and key risk factors including obesity, insulin resistance, and hyperlipidemia
Liposomal technology is an advanced delivery and absorption formula that gets absorbed more easily
Throughout the last three decades, the number of CSCCs has climbed from 50 to 300%, and by 2030, their frequency in European countries will be twice as high as it is now
Infection warning signs: Timing: Symptoms appear or worsen 2 to 5 days after injection (delayed compared to reaction symptoms) Redness: Progressively expanding, bright red, with distinct borders Pain: Increasing rather than decreasing over time Warmth: Injection site feels significantly warmer than surrounding skin Drainage: Yellow or green pus, cloudy fluid, or foul odor Systemic: Fever, chills, general malaise If you suspect infection, do not attempt to treat it at home with warm compresses or over-the-counter antibiotics
Shortness of breath goes to pulmonology
